Urinary calculi. Part 1: Epidemiologie, diagnostic laboratory tests, genetic aspects and infections;Harnsteine. Teil 1: Epidemiologie, labordiagnostik, genetik und infekte

Urologe - Ausgabe A

Volumn 41, Issue 5, 2002, Pages 496-508

  Hesse, Albert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACIMETHIN; ALLOPURINOL; ANTIBIOTIC AGENT; ASCORBIC ACID; BLEMAREN; CAPTIMER; CEPHALOSPORIN; CITRIC ACID; COTRIMOXAZOLE; GYRASE INHIBITOR; LITHUREX; MAGNESIUM; METHIONINE; NITROXOLINE; PYRIDOXINE; TIOPRONIN; URALYT U;

BARTTER SYNDROME; CYSTINURIA; DIAGNOSTIC TEST; GENETIC ANALYSIS; HUMAN; HYPERCALCIURIA; INCIDENCE; KIDNEY CALCIFICATION; KIDNEY TUBULE ACIDOSIS; LABORATORY TEST; LESCH NYHAN SYNDROME; OXALOSIS 1; PH MEASUREMENT; PREVALENCE; REVIEW; URINARY TRACT INFECTION; UROLITHIASIS; XANTHINURIA;

EID: 0036943820     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-002-0235-x     Document Type: Review

References (46)

1. Asper R, Schmucki O (1982) Cystinurietherapie mit Ascorbinsäure. Urol Int 37: 91
2. Berg W, Schanz H, Eisenwinter B, Schorch P (1992) Häufigkeitsverteilung und Trendentwicklung von Harnsteinsubstanzen. Auswertung von über 210 000 Harnsteinanalysedaten aus dem Gebiet der ehemaligen DDR. Urologe A 31: 98-102
3. Berg W, Janitzky V, Schubert J (1998) Einfacher Schnelltest zur Bestimmung von Zystin im Urin. Urologe B 38: 151-153
4. Birwé H, Schneeberger W, Hesse A (1991) Investigations of the efficacy of ascorbic acid therapy in cystinuria. Urol Res 19: 199-201
5. Bongartz D,Schneider A, Hesse A (1997) Test zur Einschätzung des Harnsteinbildungsrisikos. T & E Urol Nephrol 9: 360-362
6. Bongartz D, Schneider A, Hesse A (1999) Direct measurement of the calcium oxalate nucleation with a laser probe. Urol Res 27: 135-140
7. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77-84
8. Brindle E, Hautmann R, Alken P, Hesse A, Schäfer R (1997) Leitlinien zur Diagnostik und Therapie urologischer Erkrankungen - Urolithiasis. Urologe A 36: 578-593
9. Cameron JS, Moro F, Simmonds HA (1993) Gout, uric acid and purine metabolism in paediatric nephrology. Pediatr Nephrol 7: 105-118
10. Curhan GC, Rimm EB, Willett WC, Stampfer MJ (1994) Regional variation in nephrolithiasis incidence and prevalence among united states men. J Urol 151: 838-841
11. Di Silverio F, Riccinti GP, Grillenzoni L, De Marco F (1997) Incidence and recurrence of stones after ESWL. Curr Opin Urol 7: 231-233
12. Ettinger B, Pak CYC, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158: 2069-2073
13. Ganter K,Winter P, Brockhaus S, Hesse A (1996) Alkalisierung des Hams zur Metaphylaxe bei Kalziumoxalatsteinen: K-Zitrat vs. Na-K-Zitrat. Urologe B 36: 461-465
14. Goodman HO, Holmes RP, Assimos DG (1995) Genetic factors in calcium oxalate stone disease. J Urol 153: 301-307
15. Hesse A, Schneider HJ, Hienzsch (1972) Die infrarotspektroskopische Harnsteinanalyse. Dtsch Med Wochenschr 97: 1694-1701
16. Hesse A, Thon A, Classen A, Birwé H (1988) Diagnostic and therapy-control of inborn metabolic disorders by high performance liquid chromatography: 2,8-dihydroxyadeninuria, xanthinuria. Chromatographia 25: 205-209
17. Hesse A, Bongartz D, Struwe F, Schoeneich G (1997) Senkung des Risikos der Phosphatsteinbildung durch L-Methionin. Urologe B 37: 489-492
18. Hesse A, Siener R (1997) Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 15: 165-171
19. Hesse A, Heimbach D (1999) Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification. World J Urol 17: 308-315
20. Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P (2002) Aktuelle Daten zur Prävalenz und Inzidenz des Harnsteinleidens in Deutschland. Deutscher Urologenkongress, Wiesbaden
21. Hesse A, Hoppe B (2000) Genetik der Urolithiasis im Kindesalter. In: Wullich B, Zang K (Hrsg) Genetik von Krankheiten des Urogenitalsystems. Springer, Berlin Heidelberg New York Tokio, S 257-274
22. Hesse A, Tiselius H-G, Jahnen A (2002) Urinary stones, diagnosis, treatment and prevention of recurrence, 2nd edn. Karger, Basel
23. Holmes RP, Assimos DG, Goodman HO (1998) Genetic and dietary, influences on urinary oxalate excretion. Urol Res 26: 195-200
24. Hönow R, Hesse A (2002) Comparison of extraction methods for the determination of soluble and total oxalate in foods by HPLC-enzyme-reactor. Food Chem (in press)
25. Jaeger P, Portmann L, Saunders A, Rosenberg LF, Thier SO (1986) Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med 315: 1120-1123
26. Jacobs D, Heimbach D, Hesse A (2001) Chemolysis of struvite stones by acidification of artificial urine: an invitro study. Scand J Urol Nephrol 35: 345-349
27. Laube N, Schneider A, Hesse A (2000) A new approach to calculate the risk of calcium oxalate crystallization from unprapered native urines. Urol Res 28: 274-280
28. Laube N, Labedzke V, Hergarten S, Hesse A (2002) Determination in urinary calcium-oxalate formation risk with BONN-Risk-Index and EQUIL, applied to a family. J Chem Inf Comput Sci (in press)
29. Laube N, Schmidt M, Hesse A (2002) Die Überwachung des Behandlungserfolges von Kalziumoxalat-Steinpatienten mit Hilfe des BONN-Risk-Index. Urologe A (in press)
30. Leusmann DB, Blaschke R, Schmandt W (1990) Results of 5035 stone analysis: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephral 24: 205-210
31. Nolde A, Hesse A, Scharrel O, Vahlensieck W (1993) Modellprogramm zur Nachsorge bei rezidivierenden Harnsteinpatienten. Urologe B 33: 148-154
32. Pak CYC, Kaplan RA, Bone H,Townsend J, Woters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292: 497-500
33. Pak CYC, Peterson R, Poindexter JR (2001) Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 165: 378-381
34. Parks JH, Goldfisher E, Asplin JR, Coe FL (2002) A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167: 1607-1612
35. Pras E,Arber N, Aksentijevitsch I et al. (1994) Localization of a gene causing cystinuria to chromosome 2p. Nat Genet 6: 415-419
36. Schubert G (1996) 70.000 Urinary stone-analysis. Urolithiasis 1996: 452-453
37. Stark R, Hesse A (2000) Harnstein-Nachsorge in der urologischen Praxis. Congress Compact Verlag, Berlin
38. Strauwen P, Hesse A, Thon A, Behrend H (1989) Xanthinuria with nephrolithiasis in infancy. Aktuel Urol 20: 218-222
39. Strohmaier WL (2000) Volkswirtschaftliche Aspekte des Harnsteinleidens und der Harnsteinmetaphylaxe. Urologe A 39: 166-170
40. Tiselius H-G (1997) Risk formulas in calcium oxalate urolithiasis. World J Urol 15: 176-185
41. Tiselius H-G, Ackermann D, Alken P, Buck C, Conort P, Gallucci M (2001) Guidelines on Urolithiasis, European Association of Urology
42. Trinchieri A (1996) Epidemiology of urolithiasis. Arch Ital Urol 68: 203-249
43. Vahlensieck E.W. Bach D, Hesse A (1982) Incidence, prevalence and mortality of urolithiasis in the German Federal Republic. Urol Res 10: 161-164
44. Brändle E et al. (1997) Leitlinien zur Diagnostik und Therapie urologischer Erkrankungen - Urolithiasis - Urologe A 36: 578-593
45. Tiselius H-G et al. (2001) Guidelines on Urolithiasis, European Association of Urology
46. Hesse A, Tiselius H-G, Jahnen A (2002) Urinary stones, Diagnostic, Treatment and Prevention of Recurrence. Karger, Basel, 2nd revised and enlarged edition